Hizentra® (Subcutaneous Immunoglobulin (SCIG)) Brand: CSL BehringCategory: Finished Products Brand name: Hizentra® Generic name: Subcutaneous Immunoglobulin (SCIG) Indication: Replacement therapy in adults and children in primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia common variable immunodeficiency severe combined immunodeficiency and Wiskott-Aldrich syndrome IgG subclass deficiencies with recurrent infections Replacement therapy in myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. Dosage form: Solution for subcutaneous injection, Vial, 200g, 5ml Solution for subcutaneous injection, Vial, 200g, 10ml Solution for subcutaneous injection, Vial, 200g, 20ml Manufacturer: CSL Behring AG Country of origin: Switzerland
